Latest Breaking News On - Biocon biologics limited - Page 1 : comparemela.com

Eris Lifesciences Q4 results: Net profit up 29.5% to Rs 79.6 crore

Eris Lifesciences Q4: Revenue came in at Rs 550.9 crore, up 36 percent from the year-ago quarter

Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges

Biocon shares in focus today as US FDA issues four observations for insulin facility

Biocon stock ended 2.05% higher at Rs 276.50 on Thursday against the previous close of Rs 270.95 on BSE. The stock touched an intraday high of Rs 277.60 .

US FDA issues 4 observations for Biocon Biologics' insulin facility

The trigger for this inspection was a Pre-Approval Supplement (PAS) filed by BBL s customer late last year

Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®